Previous Close | N/A |
Open | N/A |
Bid | N/A |
Ask | N/A |
Strike | N/A |
Expire Date | N/A |
Day's Range | N/A - N/A |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
On June 3, 2024, Julie Hambleton, Director at SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 4,648 shares of the company.
Badreddin Edris, the Chief Operating Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), sold 20,000 shares of the company on June 3, 2024, according to a recent SEC filing.
On June 3, 2024, Saqib Islam, the Chief Executive Officer of SpringWorks Therapeutics Inc (NASDAQ:SWTX), executed a sale of 49,000 shares of the company.